How Much Did AliveCor Raise? Funding & Key Investors

What Is AliveCor?

AliveCor, founded in 2010 by Bruce Satchwell and David Albert, is based in Mountain View, California. The company specializes in mobile heart solutions, offering FDA-cleared devices and applications that transform smartphones into clinical-quality electrocardiogram (ECG) recorders.

With a workforce of 101-250 employees, AliveCor is dedicated to modernizing healthcare through innovative technology. Their product lineup includes the KardiaMobile series and the Kardia 12L, designed for accurate and convenient cardiac monitoring.

AliveCor's mission is to save lives and reduce healthcare costs by providing proactive heart care solutions. Their machine learning techniques and comprehensive cardiac care programs are recognized globally for transforming cardiac care.

How Much Funding Has AliveCor Raised?

1. Series A
   • Amount Raised: $3M
   • Date: August 2011
   • Lead Investors: Burrill & Company
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To develop and launch their initial mobile ECG products.
2. Series B
   • Amount Raised: $10.5M
   • Date: June 2012
   • Lead Investors: Khosla Ventures
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To expand product development and market reach.
3. Series C
   • Amount Raised: $20M
   • Date: March 2016
   • Lead Investors: WP Global Partners
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To scale operations and enhance product offerings.
4. Series D
   • Amount Raised: $30M
   • Date: March 2017
   • Lead Investors: Mayo Clinic, Omron Healthcare
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To accelerate growth and expand into new markets.
5. Debt Financing
   • Amount Raised: $20M
   • Date: January 2019
   • Lead Investors: Oxford Finance LLC
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To provide working capital for expanding the footprint of mobile ECG devices.
6. Private Equity Round
   • Amount Raised: Not publicly disclosed
   • Date: October 2019
   • Lead Investors: Not publicly disclosed
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To support ongoing product development and market expansion.
7. Venture Round
   • Amount Raised: $5.8M
   • Date: October 2019
   • Lead Investors: Not publicly disclosed
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To further develop and expand mobile ECG devices.
8. Series E
   • Amount Raised: $65M
   • Date: November 2020
   • Lead Investors: Bold Capital Partners, Khosla Ventures, Omron Healthcare, Qualcomm Ventures, WP Global Partners
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To enhance product innovation and expand market presence.
9. Series F
   • Amount Raised: Not publicly disclosed
   • Date: August 2022
   • Lead Investors: GE Healthcare
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To drive further innovation and growth in mobile heart solutions.

Total Amount Raised: $154.3M

Current Valuation: Not publicly disclosed

Key Investors

• GE Healthcare
  • Details: GE Healthcare is a leading global medical technology and digital solutions innovator. They provide transformational medical technologies and services that are shaping a new age of patient care.
  • Investment Focus Areas: Medical imaging, diagnostics, patient monitoring.
  • Notable Investments: Arterys, HeartFlow, Day Zero Diagnostics.
• Khosla Ventures
  • Details: Khosla Ventures is a venture capital firm founded by Vinod Khosla, focusing on impactful technology investments. They support entrepreneurs building impactful technology companies.
  • Investment Focus Areas: Healthcare, artificial intelligence, sustainability.
  • Notable Investments: Square, DoorDash, Impossible Foods.
• Omron Healthcare
  • Details: Omron Healthcare is a global leader in the field of clinically proven, innovative medical equipment for health monitoring and therapy. They are committed to improving lives and contributing to a better society.
  • Investment Focus Areas: Blood pressure monitors, respiratory care, pain management.
  • Notable Investments: AliveCor, iRhythm Technologies, PhysIQ.
• WP Global Partners
  • Details: WP Global Partners is a private equity firm that provides investment management services. They focus on delivering superior returns through a diversified portfolio.
  • Investment Focus Areas: Private equity, venture capital, real assets.
  • Notable Investments: AliveCor, Uber, Airbnb.
• Bold Capital Partners
  • Details: Bold Capital Partners is a venture capital firm that invests in early-stage and growth-stage companies. They focus on transformative technologies that have the potential to change the world.
  • Investment Focus Areas: Biotechnology, artificial intelligence, robotics.
  • Notable Investments: SpaceX, Vicarious, Matternet.

What's Next for AliveCor?

AliveCor stands at the cusp of significant growth opportunities, driven by the expanding market for mobile ECG devices and the increasing adoption of telemedicine. With FDA clearances for products like the KardiaMobile 6L, the company is well-positioned to capitalize on the growing demand for remote cardiac monitoring solutions.

Future fundraising efforts are likely to focus on scaling operations and enhancing product offerings. The recent $5.8 million equity financing and a $20 million loan from Oxford Finance underscore the financial backing available to support these ambitions. However, navigating regulatory landscapes and staying ahead of competitors in the wearable medical device market will be critical challenges.

Use Clay to Get Funding Data

Sales professionals, take your strategy to the next level by leveraging Clay's platform to access comprehensive fundraising data on companies like AliveCor and gather other critical business insights.

Sign up for free on Clay and start transforming your sales approach today.